Results 231 to 240 of about 197,418 (252)

Circadian Deregulation in Multiple Myeloma: BMAL1/CLOCK Expression Patterns and Diagnostic Performance

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1123-1132, October 2026.
ABSTRACT Background Circadian clock disruption has emerged as a relevant axis in cancer; however, the expression patterns and diagnostic relevance of BMAL1 and CLOCK in multiple myeloma (MM) remain insufficiently defined. Methods BMAL1 and CLOCK mRNA expression was quantified by RT‐qPCR in bone marrow samples from 46 newly diagnosed MM patients and 13 ...
Hamide Albayrak, Mustafa Ertan Ay, Anıl Tombak, Kenan Çevik, Özlem İzci Ay, Tuba Kabasakal, Mehmet Emin Erdal   +6 more
wiley   +1 more source

Oxidized phosphatidylcholines inhibit airway smooth muscle β2-adrenergic receptors via protein kinase C. [PDF]

Am J Respir Cell Mol Biol
Vaghasiya J, Sikarwar A, Dalvand A, Basu S, Bagan A, Varghese N, Duaqui AA, Pandey D, Mishra S, Ravandi A, Pascoe CD, Halayko AJ, Canadian Respiratory Research Network.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

Cell Metabolism, 2022
Libbey O'Farrell, Matthew M Abernathy, Ruth E Gimeno   +2 more
exaly  

Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy

Journal of Diabetes Investigation, 2023
Tetsuya Kubota, Yukiko Onishi, Masahiko Iwamoto   +2 more
exaly  

Agonist antibody discovery: Experimental, computational, and rational engineering approaches

Drug Discovery Today, 2022
Harkamal Jhajj, Peter M. Tessier
exaly  

The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes

Cell Metabolism, 2017
Christophe Schmitt, Matthias Tschöp, Richard DiMarchi   +2 more
exaly  

Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors

British Journal of Pharmacology, 2008
P G Strange
exaly  

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial

Fertility and Sterility, 2014
Arri Coomarasamy, Yacoub Khalaf, Sesh Kamal Sunkara   +2 more
exaly  

Radiolabelling of the human 5-HT receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities

Biochemical Pharmacology, 1996
A J Sleight, Vincent Mutel, Andrew J Sleight   +2 more
exaly  

Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos

Fertility and Sterility, 2012
Juan Antonio Garcia-Velasco, Juan A Garcı́A-Velasco   +1 more
exaly